Welcome to our dedicated page for BACQ SEC filings (Ticker: BACQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BACQ filings document a blank-check issuer’s public-company structure, material events and SPAC-related securities. The record includes registration-statement disclosures, 8-K reports on material agreements, shareholder voting matters, governance items, capital-structure changes, risk factors, and operating and financial results.
Filings also identify the issuer’s listed securities, including Class A ordinary shares, units and rights, and include a Form 25 notice covering the withdrawal of rights and units from Nasdaq listing and registration. These disclosures frame the issuer’s formal record around SPAC mechanics, security status and corporate-event reporting.
Merlin, Inc. director Carolyn Trabuco filed an initial Form 3, which is a required statement of beneficial ownership for new insiders. The data provided shows no reported purchases, sales, exercises, gifts, or other transactions, indicating this is a baseline disclosure of insider status rather than a trading event.
Merlin, Inc. reported that Bleichroeder Sponsor 1 LLC, the SPAC sponsor, converted its derivatives into common equity in connection with the closing of the business combination with Merlin Labs, Inc. Each Class B ordinary share converted into one Class A ordinary share and then into one share of common stock.
The sponsor converted 8,333,333 Class B ordinary shares into 8,333,333 Class A ordinary shares and then common stock, and 425,000 rights into 42,500 shares of common stock, all at an exercise price of $0. Following these transactions, the sponsor holds 8,800,833 shares of common stock directly.
MC Advisory L.L.C-FZ, managed by co-founder Michel Combes, and former executive chairman Andrew Gundlach are managing members of the sponsor and have voting and investment discretion over these shares, while each disclaims beneficial ownership beyond any pecuniary interest.
Inflection Point Acquisition Corp. notified the removal of its Rights, Units from listing and registration on the Nasdaq Stock Market LLC. The Form 25 cites Nasdaq compliance with 17 CFR 240.12d2-2 and the issuer's compliance with the Exchange's rules for voluntary withdrawal; an expiry date appears as March 31, 2018.
Inflection Point Acquisition Corp. IV is a Cayman Islands SPAC that raised $250,000,000 in its IPO by selling 25,000,000 units at $10.00 each, with proceeds held in a U.S. trust account for an eventual business combination.
The company has agreed to a proposed business combination with Merlin Labs, Inc., valuing Merlin at a $800,000,000 purchase price, with consideration in New Merlin Common Stock determined by the per-share redemption price. The structure includes domestication to Delaware, a merger via a wholly owned merger sub, and a post-closing name change to Merlin, Inc.
Supportive financing includes approximately $78 million plus $9.3 million of Merlin pre-funded convertible notes and warrants, and a Series A preferred PIPE totaling $100 million from a lead investor and $20 million from additional investors. Shareholders and Merlin stockholders approved the transaction, and Inflection Point expects to close the business combination on March 16, 2026, after offering public shareholders redemption rights and satisfying regulatory and listing conditions.
Inflection Point Acquisition Corp. IV reported that shareholders approved all proposals presented at an extraordinary general meeting connected to its planned business combination with Merlin Labs, Inc., as described in its proxy statement/prospectus. The meeting achieved a quorum with 20,358,101 ordinary shares, or 60.31% of those outstanding as of February 2, 2026, represented in person or by proxy.
Each proposal received substantially more votes "for" than "against," and the company did not need to use an adjournment proposal because support levels were sufficient. Shareholders also backed the company’s slate of directors, with each nominee receiving significantly more votes "for" than votes withheld.
Inflection Point Acquisition Corp. IV discloses Merlin Labs completed the Preliminary Design Review (PDR) for its C-130J autonomy program. The PDR approval is part of a $105 million Indefinite Delivery, Indefinite Quantity contract and clears the way to enter the Critical Design phase.
Merlin states its preliminary integration design and airworthiness approach for demonstration were approved, and next steps include system integration, ground testing, and takeoff-to-touchdown flight demonstrations.
INFLECTION POINT ACQUISITION CORP. IV reported mixed insider trading activity by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC in its Class A common stock. Between November 28 and December 9, 2025, Goldman Sachs, acting as a market maker, executed multiple open-market purchases and sales.
The transactions totaled 4,328 shares purchased and 4,872 shares sold, for a small net sale of 544 shares, at prices generally around $10.71–$11.00 per share. After these trades, indirect ownership stood at roughly 3.25 million shares.
The common stock is held directly by Goldman Sachs and indirectly by The Goldman Sachs Group, Inc., which disclaim beneficial ownership except to any pecuniary interest. They state that any profit potentially recoverable under Section 16(b) from these trades will be remitted to the issuer, and that on February 5, 2026, they ceased to be greater-than-10% beneficial owners of the Class A common stock.
Inflection Point Acquisition Corp. disclosed an update on its previously announced business combination with Merlin Labs, Inc., noting that Merlin will host an Investor & Analyst Webinar on March 3, 2026 at 1:00pm ET featuring a presentation and Q&A with management.
The filing reiterates that the merger remains subject to the terms of the Business Combination Agreement and references a filed Form S-4 and a definitive proxy statement/prospectus that has been mailed to Inflection Point shareholders for their consideration.
Inflection Point Acquisition Corp. IV filed an 8-K highlighting a press release from Merlin Labs, Inc., its proposed merger partner, announcing an Investor & Analyst Webinar on March 3, 2026 at 1:00pm ET. The event will feature a presentation and Q&A with Merlin’s management, with a replay available on Merlin’s investor relations website.
The filing reiterates that Inflection Point and Merlin entered into a Business Combination Agreement on August 13, 2025 and that a Form S-4 registration statement with a proxy statement/prospectus has been filed and mailed to Inflection Point shareholders for their vote on the business combination. Merlin is described as an aerospace and defense technology company focused on autonomous flight, supported by $100M+ total in awarded contracts from military customers.